Epidemiology and Clinical Significance of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia shows a strong age-dependent pattern, with histopathologic evidence beginning to appear after age 40, and prevalence exceeding 50% by age 60, and as high as 90% by age 85, according to The Journal of Urology 1
By age 80, prevalence reaches approximately 80% 2

Symptom Prevalence

Approximately half of all men with histologic BPH develop moderate to severe lower urinary tract symptoms, with the prevalence of bothersome symptoms increasing with age, similar to histologic evidence, as reported by The Journal of Urology 1
The impact of lower urinary tract symptoms on quality of life is highly variable and not directly related to measurable physiological factors 1

BPH-associated mortality is rare in the United States, with serious complications being uncommon, though the risk of acute urinary retention increases with age, according to The Journal of Urology 1
The American Urological Association notes that BPH has substantial and increasing influence on morbidity, quality of life, and healthcare costs due to the aging population is not mentioned, however, BPH-associated mortality and serious complications are rare 1

BPH develops due to an imbalance between cellular growth and apoptosis favoring growth in the prostatic transition zone, leading to benign prostatic enlargement and potential obstruction, as described by Praxis Medical Insights 2
BPH contributes to lower urinary tract symptoms through direct obstruction from enlarged tissue and increased smooth muscle tone and resistance 2, 3